Ingevity Corporation (NYSE:NGVT – Get Free Report) CEO David Li sold 5,000 shares of the firm’s stock in a transaction dated Wednesday, August 12th. The shares were sold at an average price of $76.62, for a total transaction of $383,100.00. Following the completion of the transaction, the chief executive officer directly owned 135,636 shares in the company, valued at approximately $10,392,430.32. This represents a 3.56% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Ingevity Stock Performance
NYSE NGVT opened at $76.53 on Monday. The company has a current ratio of 1.61, a quick ratio of 1.15 and a debt-to-equity ratio of 22.52. The firm has a market capitalization of $2.63 billion, a price-to-earnings ratio of 52.06 and a beta of 1.16. The firm’s 50 day simple moving average is $73.57 and its 200 day simple moving average is $71.66. Ingevity Corporation has a 1 year low of $45.85 and a 1 year high of $79.29.
Ingevity (NYSE:NGVT – Get Free Report) last announced its quarterly earnings data on Wednesday, July 29th. The company reported $1.74 EPS for the quarter, beating the consensus estimate of $1.33 by $0.41. Ingevity had a net margin of 4.65% and a return on equity of 284.70%. The business had revenue of $314.10 million during the quarter, compared to the consensus estimate of $312.20 million. Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. As a group, research analysts expect that Ingevity Corporation will post 5.4 earnings per share for the current fiscal year.
Analysts Set New Price Targets
Read Our Latest Research Report on NGVT
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently made changes to their positions in the company. BlackRock Inc. acquired a new position in shares of Ingevity during the second quarter worth $400,545,000. Principal Financial Group Inc. increased its holdings in Ingevity by 269.9% in the fourth quarter. Principal Financial Group Inc. now owns 652,237 shares of the company’s stock valued at $38,599,000 after purchasing an additional 475,907 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in Ingevity by 311.8% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 600,380 shares of the company’s stock worth $23,769,000 after purchasing an additional 454,579 shares during the last quarter. Simcoe Capital Management LLC raised its position in Ingevity by 188.8% during the 2nd quarter. Simcoe Capital Management LLC now owns 624,935 shares of the company’s stock worth $26,928,000 after purchasing an additional 408,508 shares during the last quarter. Finally, Boston Partners lifted its holdings in Ingevity by 141.6% during the 4th quarter. Boston Partners now owns 620,360 shares of the company’s stock worth $36,719,000 after buying an additional 363,584 shares during the period. Institutional investors and hedge funds own 91.59% of the company’s stock.
Ingevity Company Profile
Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.
The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.
Recommended Stories
- Five stocks we like better than Ingevity
- The Metals Company’s Big Bet Now Comes Down to a License
- OneSpaWorld Keeps Turning Cruise Demand Into Record Earnings
- Meta and Tesla Are Rebounding From Oversold Levels—Now What?
- AMG’s Alternatives Boom Powers Record Growth
Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.
